MétaCan
Menu
Back to cohort
Record W4396994465 · doi:10.1681/asn.20213210s1550d

Follistatin Is a Potential Novel Therapeutic Agent for Essential Hypertension

2021· article· en· W4396994465 on OpenAlexaff
Ann Kuganathan, Marcos S. Leal, Chao Lü, Bo Gao, Jeffrey G. Dickhout, Joan C. Krepinsky

Bibliographic record

VenueJournal of the American Society of Nephrology · 2021
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer, Lipids, and Metabolism
Canadian institutionsMcMaster University
Fundersnot available
KeywordsFollistatinMedicineInternal medicinePharmacologyEndocrinologyIntensive care medicine

Abstract

fetched live from OpenAlex

Background: Follistatin (FST) is an inhibitor of several members of the profibrotic TGFb superfamily. It is highly effective at neutralizing activins, without activity against TGFb1 itself. Activins are known to induce inflammation, oxidative stress and fibrosis, all of which contribute to the vascular dysfunction characteristic of hypertension (HTN). We previously showed that FST inhibits kidney fibrosis, improves kidney function and lowers blood pressure (BP) in a hypertensive chronic kidney disease mouse model. While this is a model of secondary HTN, here we seek to analyze the efficacy of FST in improving BP and vascular structure and function in a model of essential HTN. Methods: Telemeters were implanted in the abdominal aorta of spontaneously hypertensive rats (SHR), a model of essential HTN, and normotensive control Wistar Kyoto (WKY) rats for wireless BP monitoring. Rats were treated with 0.075mg/kg FST or vehicle IP every other day from 12-20 weeks of age (8 weeks). BP was recorded weekly. First branch mesenteric arteries were harvested for analysis of vascular function using myography, assessed for oxidative stress by DHE, or formalin fixed for IHC. Results: By the end of the study, FST significantly lowered both systolic and diastolic BP in SHRs (200 +/- 9 over 132 +/- 4 mmHg in control and 189 +/- 2 over 123 +/- 2 mmHg in FST-treated SHRs, P < 0.04 and P < 0.03 respectively). SHR vessels showed increased contractility with the a1 adrenergic agonist phenylephrine, which was attenuated by FST. Impaired endothelium-dependent relaxation in SHR vessels was also improved by FST. Structurally, FST-treated vessels had less collagen deposition, assessed by Trichrome, which was accompanied by a reduction in medial thickness. Increased oxidative stress seen in SHR vessels was inhibited by FST. Conclusions: FST lowers BP in SHR with established HTN, at least in part by reducing vascular oxidative stress and medial thickening. This manifests as improved vascular function, with decreased hypersensitivity to contractile agents and improved endothelial function. Future work will identify the effects of FST on inflammation, and the role of specific activins in essential HTN. Funding: Private Foundation Support

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.002
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.269
Teacher spread0.254 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the American Society of NephrologySame topicCancer, Lipids, and MetabolismFrench-language works237,207